Respiratory Syncytial Virus RSV is a common respiratory virus primarily affecting young children Here are some remedies to ...

Older people should take a new vaccine to protect them against Respiratory Syncytial Virus (RSV), according to new research ...

Respiratory syncytial virus (RSV) is a leading cause of severe illness in infants, with no effective treatment. Results of a phase 2 trial suggested that ziresovir may have efficacy in the ...

Leaders from the Pennsylvania Departments of Health and Insurance this week encouraged all Pennsylvanians to stay up to date on their annual vaccinations to protect against flu, COVID-19, and ...

Enanta Pharmaceuticals' EDP-323 shows promising Phase 2a trial results, significantly reducing RSV viral load and symptoms ...

Figures show flu killed almost as many people as Covid over the past two winters as people are urged to get protected against ...

Fall brings cooler days and more time indoors. This makes it easier for viruses like influenza, COVID-19 and respiratory ...

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for ...

Forecasts suggest respiratory infections will be similar to last year's season. Vaccination rates will be a factor in the ...

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its advanced ...

Respiratory syncytial virus, or RSV, season is just a few months away, but new vaccine options have already arrived for ...

Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio"), a clinical stage biopharmaceutical company focused on the development of ...